|
|
| |
Over the last year, Splenda made one of the more dramatic leaps to the top of its segment of any consumer packaged good. Propelled by its taste, its reputation for healthfulness, its versatility and its association with thousands of products ranging from Diet V8 Splash to Blue Bunny sugarless yogurts, the product manufactured and marketed by Johnson & Johnson’s McNeil Nutritionals unit overtook long-time market-share leader Equal in dollar sales during the last two weeks of January.
“We’ve done a great job of redefining sweetness, and it’s great to see it pay off,” says Anne Rewey, Splenda marketing director for Ft. Washington, Pennsylvania-based McNeil. “We’re committed to the leadership position in this market.”
At least one rival doesn’t complain about Splenda’s gloating. “A lot of people felt there was no room in the marketplace for another brand, but they’ve done very well,” says Michael Decker, vice president of Pedone & Partners, the New York City advertising agency that for many years has handled all of Sweet'N Low’s marketing. “And they continue to take market share.”
Indeed, Rewey and her colleagues have lots to crow about. For the four weeks ending January 26, Splenda’s dollar-market share of the tabletop-sweetener market exceeded that of Equal-branded products for the first time, 29.7 percent to 27.2 percent, according to Information Resources Inc., a Chicago-based concern that tracks CPG sales in all mass stores except Wal-Mart. Sweet'N Low sugar substitutes stayed in third place, with a 19.5-percent market share. Those numbers further displayed momentum that began last year, when Splenda’s dollar sales rose about 69 percent while Equal’s fell by 8 percent and Sweet'N Low’s rose 1 percent.
|
|
| |
The dramatic success of Splenda has shaken things up in the artificial-sweetener business, which had been dominated for decades by the nasty rivalry between Equal and Sweet'N Low. Each of the three brands now has come up with a new approach to deal with the fresh dynamics of the marketplace. Recently hatched advertising campaigns illustrate their current strategies:
- Splenda’s spots, which debuted in January 2003, seek to reinforce the fact that the product is a derivative of actual sugar by underscoring that heritage. “What are little girls made of?” asks one 30-second spot: “Splenda and spice and everything nice.” Another chirps, “Roses are red, violets are blue, Splenda is sweet, and so are you.” After flashing images of all the sweet products that are and can be made with Splenda, the spots close with, “Think sugar, say Splenda.”
- Equal began its first big advertising effort since celebrities Cher, Lauren Hutton and Raquel Welch promoted it in the 90s. Its new ads feature B. Smith, the stylish restaurant owner and celebrity chef, who touts the brand and a cheesecake recipe that includes the product. The spots still take a veiled dig at Sweet'N Low, however, saying: “No aftertaste, like with some sweeteners.”
- Sweet'N Low has abandoned its slogan of many years, “For many people, there’s just no equal,” in favor of a higher-road effort that underscores the brand’s ubiquity by reviving an old tag line, “Wherever you go, Sweet'N Low.” The most recent TV ad depicts a janitor at an observatory sneaking a peek at Jupiter through a big telescope. He sees aliens engaging in normal, earthling-like activities such as vacuuming and doing aerobics -- and then spots a bowl of Sweet'N Low packets on a kitchen counter.
But make no mistake: Splenda is the category’s big story these days. Splenda is the brand name for sucralose, a sugar derivative, which is made through a patented multi-step process that converts natural sugar cane to a no-calorie, non-carbohydrate sweetener. The result, McNeil says, is that the body doesn’t recognize Splenda as sugar or carbohydrate and doesn’t metabolize it, making it calorie-free.
McNeil finally launched Splenda as an ingredient to food companies in 1998, after US Food and Drug Administration (FDA) clearance. In addition to its taste, part of Splenda’s appeal was its durability as an ingredient -- a crucial property to product formulators. Now it’s contained in more than 3,000 products, and Splenda has become a co-brander with a growing number of formulators.
|
| |
|
Velvet Ice Cream Co., for instance, just enlarged the Splenda logo on its fast-growing, no-sugar line of ice creams. “That Splenda logo is what consumers read first, and then they see what flavor it is,” says Lucenda Dager, vice president of sales and marketing for the Utica, Ohio-based company. Velvet just introduced Moose Tracks as its sixth flavor in the Splenda-based line. The line’s sales are 35 percent higher than the company’s previous sugarless products, which used NutraSweet (another aspartame product that is Equal’s corporate cousin) and it is rising as a percentage of the company’s overall sales.
Rewey says food companies are coming to understand the essence of the Splenda proposition, which revolves around choice. “A large percentage of consumers want different choices: 75 percent are ‘regular’ consumers versus diet consumers, and they prefer regular products,” she says. “But they want more choices around how much sugar or calories they get in a variety of products throughout the day.”
McNeil launched Splenda direct to consumers as a tabletop and cooking sweetener in 2000. Demand outstripped supply within a few months, so the company pulled back on marketing until after its new Splenda plant in Alabama opened in 2001. Since then, Splenda has launched a blistering marketing assault on Equal and Sweet'N Low.
One reason the market has proven so receptive to Splenda’s message is that McNeil uses “viral” marketing, taking advantage of the fact that a significant minority of Splenda users become absolutely fanatical about the product -- and that they tend to tell others about their experience with the ingredient. Much of this has taken place on the Internet, Rewey explains, because the best place for consumers to obtain Splenda after its 1998 debut up through 2001, when the Alabama plant came up, was online. “We had the ‘Net buzz and chat-room stuff going,” she says.
McNeil also patiently built the product-benefit and regulatory case for Splenda over the several years that the FDA was evaluating its safety. McNeil courted doctors, dietitians and other health-care providers “to make sure they knew about the soundness of Splenda,” Rewey says. The company would attend conventions about nutrition and provide product samples and information. “We did this because lots of customers want to know, ‘Is this OK for me and can I trust it?’ ” Rewey says. Its case was buttressed in January when Dr. Robert Atkins, originator of the increasingly popular Atkins Diet, endorsed sucralose and even Splenda by name as the healthiest artificial sweetener in an appearance on American talk show Larry King Live.
Splenda’s increasing patina as a healthful and even “natural” product riles rivals, because while it starts out as sugar, it ends up as the very chemical substance sucralose. “Look at the chemical structure of the compounds,” notes Ted Ziemann, president of the Health & Food Technologies division of Cargill Inc., the Minneapolis-based commodities giant that has developed and is beginning to market its own non-sugar sweeteners.
Nevertheless, competitors also recognize that the marketing resources and prowess of Johnson & Johnson are going to buy Splenda lots of attention. “Splenda is essentially the new Equal, in that it’s coming on like gangbusters with very large advertising budgets and television campaigns and lots of spending to get shelf space,” says Decker.
So Cumberland Packing Corp., the Brooklyn, New York-based company that has manufactured saccharin-based Sweet‘N Low for four decades, is adapting. When Equal emerged as a major threat about 20 years ago, Sweet'N Low took aim at that invading brand. But with Splenda’s emergence, Decker says, “We felt that just recognizing Equal was probably too narrow.” So Sweet'N Low’s new slogan (“Wherever you go, Sweet'N Low”) nods at the brand’s history. It also has tweaked media buying in an effort to reach audiences younger than its core market of 25- to 54-year-old women, and it has redoubled efforts to place Sweet‘N Low in movies and TV shows.
Last year, Cumberland managed to get the US Congress to give saccharin a clean bill of health, 20 years after a flawed study (which administered huge quantities of the artificial sweetener to laboratory rats) produced bladder tumors. “We were able to remove the saccharin warning from all of our products, and that was a big deal,” Decker says. “We went so far as to replace the cancer warning with the Good Housekeeping Seal. We turned unfair negatives into an immediate positive.”
Decker notes that Equal has taken a much bigger hit in terms of market share from Splenda than Sweet'N Low has and says that Sweet'N Low, which is priced much lower than Splenda and Equal, remains “the number one-selling brand in terms of units and volume.”
Equal’s new, US$ 15-million ad campaign stresses the product’s food-friendly flavor. In the past, says Kim Clay, director of communications for Merisant Corp., the Chicago-based manufacturer of Equal and NutraSweet, Equal “had been considered a dieter’s brand: great taste with zero calories. That’s why we used the celebrities in the ads. But now we’re repositioning Equal as a more mainstream brand with a broader target than people who are dieting: younger women, 35-plus, who aren’t so much looking for a diet product but who want a product that allows foods to taste good without extra sugar.”
Equal has been vulnerable to Sweet'N Low’s characterization of its rival as having a bitter aftertaste, Clay concedes. “But in taste tests, lots of people think we’re the same as the pink stuff [Sweet'N Low].” Merisant also is using B. Smith’s endorsement to take a chunk out of the presumption that Equal can’t be used in baking; both Sweet'N Low and Splenda hold up better. “There are special recipes that the Equal test kitchen has developed, so Equal can be used in baking,” Clay explains. “You just have to do it a certain way, at the end of the baking cycle.”
And while Equal is no longer fighting just Sweet'N Low, Clay puts a positive spin on the new attention that Splenda has brought the sugar-substitute marketplace. “Splenda has brought new ‘news’ to the category,” she says, “which is great for all of us.” [28-Apr-2003]
|
|
|
| |
|
| |
Dale Buss is a journalist and editorial consultant in Rochester Hills, Michigan. He's a former reporter for The Wall Street Journal and a former contributing editor of Brand Marketing.
|
| |
|
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Nov 24, 2003
|
Low-Carbs: Are Brands Losing It? -- Dale Buss
|
|
|
Food and beverage brands deal with the latest trend to hit the industry: the low-carb frenzy. Is it time to throw your entire product line down the trash disposal over a trend?
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Oct 20, 2003
|
Taking Advantage of Women -- Edwin Colyer
|
|
|
Would you like a loyal customer from cradle to grave? Pharmaceutical companies are missing out on opportunities for a long-term product line for women.
|
|
|
|
|
| |
|
| |
|
Oct 6, 2003
|
Made where? -- Ron Irwin
|
|
|
English roses grown in Kenya, American skis built in China, Italian shoes made in Romania? Home brands insist offshore production is the only route for survival.
|
|
|
|
|
| |
|
Sep 29, 2003
|
Turning Over a New Leaf? -- Edwin Colyer
|
|
|
We care about our staff and the environment… right? Are businesses really improving their records on environmental responsibility? Or is this cynical marketing at work?
|
|
|
|
|
| |
|
| |
|
Sep 15, 2003
|
Pharmaceuticals Go to the Dogs -- Edwin Colyer
|
|
|
Do consumers want the same drugs as their dog? Some like Pfizer offer animal and human products all under one brand. Others like Merck and Eli Lilly prefer to keep man and beast separate.
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Jul 28, 2003
|
Samsung Shows its Strength -- Robin Rusch
|
|
|
Five years ago Samsung Electronics was a cheap Korean brand; today it’s a quality name that climbs to number 25 in Interbrand and BusinessWeek’s top global brands survey.
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
Jun 30, 2003
|
Delivering Global Brands -- Edwin Colyer
|
|
|
Global express distribution operators, like TNT and Exel, are consolidating supply chains to better service and win contracts with brands like Deutsche Post, FedEx and UPS.
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Apr 7, 2003
|
Happily Ever After? -- Dale Buss
|
|
|
Looking to ally forces in a co-branding relationship? Match-making is a skill fraught with pitfalls, but done right it can expand market and grow opportunities.
|
|
|
|
|
| |
|
Mar 31, 2003
|
The Brands We Love to Hate -- David Liss
|
|
|
What can we learn from the brands we just can't stand? WWE, Jerry Springer and NASCAR aren't as far from Tiffany's or BMW as we may like to believe.
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
Copyright © 2001-2013 brandchannel. All rights reserved.
|
|